Endoscopic ultrasound for pancreatic and periampullary tumors
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at how doctors use endoscopic ultrasound (EUS) to diagnose and manage tumors in the pancreas and nearby areas. If you have such a tumor, this study may help improve how these conditions are treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult, 18 years of age or older.
- You should have signs (from symptoms, blood tests, or imaging) that you might have a tumor in the pancreas or in the nearby area where the bile duct and pancreas meet the intestine.
- Your doctor should have recommended an endoscopic ultrasound (EUS) as part of your care.
- You must be able to understand and sign a consent form.
- If you are pregnant or breastfeeding, you cannot join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special ultrasound test to collect cells from a pancreatic tumor and study them to better predict if the cancer may come back or spread. It aims to help doctors choose the best treatment plan for each person.
This study compares a new, possibly easier-to-use ultrasound tool (EndoSound Vision System) to the standard echoendoscope for looking at organs like the pancreas, bile duct, or lymph nodes. If you are already scheduled for an endoscopic ultrasound, you may be able to join.
This study is collecting information from people who may have pancreatic cancer to see how a new ultrasound imaging technique (called LINFU) works for helping doctors decide whether a biopsy is needed. Participation could provide better imaging to guide your care.
This study tests how safe and effective endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is for treating pancreatic growths that might become cancer or already are cancer. It is for people who are already scheduled to have this procedure as part of their care.
This early-phase trial is testing a new endoscopic (from inside the stomach) approach for pancreatic ductal adenocarcinoma that is locally advanced and cannot be removed with surgery. It may help some people who have already tried first chemotherapy and still have a tumor confined to the pancreas area (no spread).
This trial studies bacteria found inside pancreatic tumors to see if they can help diagnose or predict the course of the disease. You may be eligible if you have a suspected pancreatic cancer and need a special biopsy (EUS-FNB).
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.